6 results on '"Cohen, Erica"'
Search Results
2. Increased risk for irritable bowel syndrome after acute diverticulitis.
- Author
-
Cohen E, Fuller G, Bolus R, Modi R, Vu M, Shahedi K, Shah R, Atia M, Kurzbard N, Sheen V, Agarwal N, Kaneshiro M, Yen L, Hodgkins P, Erder MH, and Spiegel B
- Subjects
- Adult, Aged, Female, Hospitals, Veterans, Humans, Incidence, Longitudinal Studies, Male, Middle Aged, Retrospective Studies, Risk Assessment, Diverticulitis complications, Irritable Bowel Syndrome epidemiology
- Abstract
Background & Aims: Individuals with diverticulosis frequently also have irritable bowel syndrome (IBS), but there are no longitudinal data to associate acute diverticulitis with subsequent IBS, functional bowel disorders, or related emotional distress. In patients with postinfectious IBS, gastrointestinal disorders cause long-term symptoms, so we investigated whether diverticulitis might lead to IBS. We compared the incidence of IBS and functional bowel and related affective disorders among patients with diverticulitis., Methods: We performed a retrospective study of patients followed up for an average of 6.3 years at a Veteran's Administration medical center. Patients with diverticulitis were identified based on International Classification of Diseases, 9th revision codes, selected for the analysis based on chart review (cases, n = 1102), and matched with patients without diverticulosis (controls, n = 1102). We excluded patients with prior IBS, functional bowel, or mood disorders. We then identified patients who were diagnosed with IBS or functional bowel disorders after the diverticulitis attack, and controls who developed these disorders during the study period. We also collected information on mood disorders, analyzed survival times, and calculated adjusted hazard ratios., Results: Cases were 4.7-fold more likely to be diagnosed later with IBS (95% confidence interval [CI], 1.6-14.0; P = .006), 2.4-fold more likely to be diagnosed later with a functional bowel disorder (95% CI, 1.6-3.6; P < .001), and 2.2-fold more likely to develop a mood disorder (CI, 1.4-3.5; P < .001) than controls., Conclusions: Patients with diverticulitis could be at risk for later development of IBS and functional bowel disorders. We propose calling this disorder postdiverticulitis IBS. Diverticulitis appears to predispose patients to long-term gastrointestinal and emotional symptoms after resolution of inflammation; in this way, postdiverticulitis IBS is similar to postinfectious IBS., (Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
3. Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy.
- Author
-
Shahedi K, Fuller G, Bolus R, Cohen E, Vu M, Shah R, Agarwal N, Kaneshiro M, Atia M, Sheen V, Kurzbard N, van Oijen MG, Yen L, Hodgkins P, Erder MH, and Spiegel B
- Subjects
- Adult, Aged, Aged, 80 and over, Colonoscopy, Female, Humans, Los Angeles epidemiology, Male, Middle Aged, Prevalence, Retrospective Studies, Risk Assessment, Veterans, Diverticulitis epidemiology, Diverticulum complications, Diverticulum diagnosis
- Abstract
Background & Aims: Colonic diverticulosis is the most common finding during routine colonoscopy, and patients often question the significance of these lesions. Guidelines state that these patients have a 10% to 25% lifetime risk of developing acute diverticulitis. However, this value was determined based on limited data, collected before population-based colonoscopy, so the true number of cases of diverticulosis was not known. We measured the long-term risk of acute diverticulitis among patients with confirmed diverticulosis discovered incidentally on colonoscopy., Methods: We performed a retrospective study using administrative and clinical data from the Veterans Affairs Greater Los Angeles Healthcare System, collecting data on patients who underwent colonoscopies from January 1996 through January 2011. We identified patients diagnosed with diverticulosis, determined incidence rates per 1000 patient-years, and analyzed a subgroup of patients with rigorously defined events confirmed by imaging or surgery. We used a Cox proportional hazards model to identify factors associated with the development of diverticulitis., Results: We identified 2222 patients with baseline diverticulosis. Over an 11-year follow-up period, 95 patients developed diverticulitis (4.3%; 6 per 1000 patient-years); of these, 23 met the rigorous definition of diverticulitis (1%; 1.5 per 1000 patient-years). The median time-to-event was 7.1 years. Each additional decade of age at time of diagnosis reduced the risk for diverticulitis by 24% (hazard ratio, 0.76; 95% confidence interval, 0.6-0.9)., Conclusions: Based on a study of the Veterans Affairs Greater Los Angeles Healthcare System, only about 4% of patients with diverticulosis develop acute diverticulitis, contradicting the common belief that diverticulosis has a high rate of progression. We also found that younger patients have a higher risk of diverticulitis, with risk increasing per year of life. These results can help inform patients with diverticulosis about their risk of developing acute diverticulitis., (Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
4. Reply: To PMID 23524129.
- Author
-
Cohen E and Spiegel B
- Subjects
- Female, Humans, Male, Diverticulitis complications, Irritable Bowel Syndrome epidemiology
- Published
- 2013
- Full Text
- View/download PDF
5. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
- Author
-
Strate LL, Modi R, Cohen E, and Spiegel BM
- Subjects
- Abdominal Pain etiology, Acute Disease, Age Distribution, Anti-Infective Agents therapeutic use, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Chronic Disease, Colic etiology, Colonoscopy, Constipation etiology, Diagnosis, Differential, Diarrhea etiology, Dietary Fiber administration & dosage, Diverticulitis complications, Diverticulitis drug therapy, Diverticulitis physiopathology, Diverticulitis, Colonic diagnosis, Diverticulitis, Colonic epidemiology, Gastrointestinal Agents therapeutic use, Gastrointestinal Motility, Health Status, Humans, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases physiopathology, Intestines microbiology, Irritable Bowel Syndrome diagnosis, Irritable Bowel Syndrome physiopathology, Mesalamine therapeutic use, Metagenome, Patient Education as Topic, Probiotics therapeutic use, Quality of Life, Rifamycins therapeutic use, Rifaximin, Terminology as Topic, Diverticulitis diagnosis, Diverticulitis epidemiology
- Abstract
Diverticular disease imposes a significant burden on Western and industrialized societies. The traditional pathogenesis model posits that low dietary fiber predisposes to diverticulosis, and fecalith obstruction prompts acute diverticulitis that is managed with broad-spectrum antibiotics or surgery. However, a growing body of knowledge is shifting the paradigm of diverticular disease from an acute surgical illness to a chronic bowel disorder composed of recurrent abdominal symptoms and considerable psychosocial impact. New research implicates a role for low-grade inflammation, sensory-motor nerve damage, and dysbiosis in a clinical picture that mimics irritable bowel syndrome (IBS) and even inflammatory bowel disease (IBD). Far from being an isolated event, acute diverticulitis may be the catalyst for chronic symptoms including abdominal pain, cramping, bloating, diarrhea, constipation, and "post-diverticulitis IBS." In addition, studies reveal lower health-related quality of life in patients with chronic diverticular disease vs. controls. Health-care providers should maintain a high index of suspicion for the multifaceted presentations of diverticular disease, and remain aware that it might contribute to long-term emotional distress beyond traditional diverticulitis attacks. These developments are prompting a shift in therapeutic approaches from widespread antimicrobials and supportive care to the use of probiotics, mesalamine, and gut-directed antibiotics. This review addresses the emerging literature regarding epidemiology, pathophysiology, and management of chronic, symptomatic diverticular disease, and provides current answers to common clinical questions.
- Published
- 2012
- Full Text
- View/download PDF
6. Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL
- Author
-
Spiegel, Brennan M. R., Reid, Mark W., Bolus, Roger, Whitman, Cynthia B., Talley, Jennifer, Dea, Stanley, Shahedi, Kamyar, Karsan, Hetal, Teal, Chassidy, Melmed, Gil Y., Cohen, Erica, Fuller, Garth, Yen, Linnette, Hodgkins, Paul, and Erder, M. Haim
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.